Quantcast

Latest Antibiotic-resistant bacteria Stories

2014-05-13 23:10:01

New Findings for EnteraGam™ (Serum-derived bovine immunoglobulin/protein isolate, SBI) Cary, NC (PRWEB) May 13, 2014 Abigail Henderson, PhD, presented new preclinical data for the prescription medical food, EnteraGam™ (serum-derived bovine immunoglobulin/protein isolate, SBI), demonstrating that the immunoglobulin-based protein mixture in SBI binds and neutralizes two types of toxins (exotoxins A and B) from several ribotypes of C. difficile, including recently isolated strains with...

2014-05-13 23:07:25

PDI, trusted leader in Infection Prevention solutions, announced the launch of its new Sani-Cloth® Pail and Refill format for Sani-Cloth® Bleach and Sani-Cloth® AF3 Germicidal Disposable Wipes. The new pail and refill packaging is specifically designed to address the needs of Environmental Services Professionals (EVS) and contains 160 pre-moistened, ready-to-use, extra-large wipes. Orangeburg, NY (PRWEB) May 13, 2014 PDI, trusted leader in Infection Prevention solutions,...

2014-05-09 23:08:57

St. Vincent Seton Specialty Hospitals cut its infection rate in half using a launderable hospital mattress cover and were awarded, along with Xavier University, an Honorable Mention for the National Association of Long Term Hospitals' (NALTH) 2014 Goldberg Innovation Award. Batesville, IN (PRWEB) May 09, 2014 St. Vincent Seton Specialty Hospitals cut its infection rate in half using a launderable hospital mattress cover and were awarded, along with Xavier University, an Honorable...

2014-05-09 08:25:42

-- Conference Call Scheduled for Thursday, May 15, 2014, at 8:30 am EDT -- ROCKVILLE, Md., May 9, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it intends to release its financial results for the three months ended March 31, 2014 on Thursday, May 15, 2014. The Company will hold an investor conference call on...

2014-05-08 08:31:53

ROCKVILLE, Md., May 8, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it has been granted new patents in Europe and has received a notice of allowance in Australia that provide composition of matter coverage for various aspects of its C. difficile (C. diff) program. The Company's extensive C. diff patent estate...

2014-05-07 11:09:15

Prioritized strategies to reduce prevalence of C. difficile in healthcare settings With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea. The guidelines are published in the June issue of Infection Control and...

2014-05-05 23:02:22

Pediatric patients with recurrent MRSA (methicillin-resistant Staphylococcus aureus) can find the help they seek at UC Davis Children’s Hospital’s new clinic. Sacramento, CA (PRWEB) May 05, 2014 Pediatric patients with recurrent MRSA (methicillin-resistant Staphylococcus aureus) can find the help they seek at UC Davis Children’s Hospital’s new clinic. The Recurrent MRSA Clinic will open Tuesday, May 6, and will be accepting referrals from primary care physicians. Dean Blumberg,...

2014-05-05 16:27:10

GERMANTOWN, Maryland, and HILDEN, Germany, May 5, 2014 /PRNewswire/ -- - FDA clearance for QIAsymphony RGQ MDx, a complete sample-to-result automation platform, marks a milestone for one of QIAGEN's major global growth drivers - U.S. launch of artus C. difficile QS-RGQ MDx Kit will provide a reliable molecular test for a widespread healthcare-associated infection - QIAGEN continues to advance pipeline with additional FDA...

2014-04-30 12:30:48

DUBLIN, Apr. 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9drj5b/hospital_acquired) has announced the addition of the "Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also...

2014-04-30 08:32:05

FIRST® - Vancomycin compounding kits make pharmacy compounding easier WOBURN, Mass., April 30, 2014 /PRNewswire/ -- CutisPharma, Inc. announced the introduction of FIRST(® )- Vancomycin oral solution compounding kits. With FIRST(®) - Vancomycin, the oral solution is compounded within a minute by adding the pre-measured white grape flavored solution to the pre-weighed vancomycin hydrochloride powder bottle and shaking it. The pleasant white grape flavor helps mask the typical...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.